# Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain

> **NCT06064058** · NA · COMPLETED · sponsor: **University of Baghdad** · enrollment: 90 (actual)

## Conditions studied

- Back Pain Lower Back Chronic
- Back Pain
- Pre Diabetes
- Diabetes
- Back Pain, Low

## Interventions

- **DIETARY_SUPPLEMENT:** Ghazwan program
- **DRUG:** Standard management

## Key facts

- **NCT ID:** NCT06064058
- **Lead sponsor:** University of Baghdad
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-30
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-09-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06064058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06064058, "Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06064058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*